TickerFactsScreenerDevelopers

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $9.7K2012: $479.7K2013: $296.9K2014: $1.72M2015: $1.97M2016: $3.86M2017: $7.92M2018: $1.42M2019: $12.00M2020: $11.95M2021: $23.57M2022: $52.78M2023: $176.74M2024: $141.47M2025: $22.67M$22.67M
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$22.67M-84.0%
2024$141.47M-20.0%
2023$176.74M+234.9%
2022$52.78M+123.9%
2021$23.57M+97.2%
2020$11.95M-0.4%
2019$12.00M+744.4%
2018$1.42M-82.1%
2017$7.92M+105.1%
2016$3.86M+95.9%
2015$1.97M+14.7%
2014$1.72M+478.5%
2013$296.9K-38.1%
2012$479.7K+4858.8%
2011$9.7K—